Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
BMC Infectious Diseases|June 15, 2021
Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case reportYuya Ito, Takahiro Takazono, Satoru Koga, et al.
Pulmonary Pharmacology & Therapeutics|June 10, 2014
Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cellsKoichi Yamada, Yoshitomo Morinaga, Katsunori Yanagihara, et al.
BMC Infectious Diseases|December 7, 2023
Luteibacter jiangsuensis blood stream infection: a first case reportTakanori Horiguchi, Makoto Sumiyoshi, Eri Nagatomo, et al.
International Journal of Antimicrobial Agents|July 30, 2013
In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosaKoichi Yamada, Katsunori Yanagihara, Norihito Kaku, et al.
Elife|July 27, 2021
Revisiting the guidelines for ending isolation for COVID-19 patientsYong Dam Jeong, Keisuke Ejima, Kwang Su Kim, et al.
Emerging Infectious Diseases|October 19, 2019
Severe Fever with Thrombocytopenia Syndrome Virus RNA in Semen, JapanSatoru Koga, Takahiro Takazono, Tsuyoshi Ando, et al.
Clinical Case Reports|February 18, 2021
Duration of antifungal therapy for septic pulmonary embolism caused by <i>Candida albicans</i> from a central venous catheter: A case reportDaisuke Okuno, Kazuhiro Oshima, Taiga Miyazaki, et al.
Japanese Journal of Infectious Diseases|April 27, 2011
Evaluation of the Cica Fungi Test Candida, a novel serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patientsTakahiro Takazono, Koichi Izumikawa, Yosuke Nagayoshi, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2016
Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α InhibitorMasataka Yoshida, Takahiro Takazono, Masato Tashiro, et al.
Clinical Therapeutics|June 7, 2025
Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis from a Multicenter Observational Study in Kyushu and Okinawa, JapanNoriho Sakamoto, Masaki Okamoto, Kazunori Tobino, et al.
Pageof 20